Novo Nordisk reported 4.44B in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
Bausch Health Companies USD 369.75M 10.14B Jun/2025
Bristol-Myers Squibb USD 2.04B 1.74B Jun/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
GlaxoSmithKline GBP 4.15B 2.8B Jun/2025
Merck USD 1.79B 0 Mar/2025
Novartis USD 793M 0 Dec/2024
Novo Nordisk 4.44B 3.99B Jun/2025
Novo Nordisk DKK 446M 0 Mar/2025
Pacira USD 44.9M 44.85M Jun/2025
Sanofi 1.22B 36.5M Jun/2025
Supernus Pharmaceuticals USD 56.12M 130K Jun/2025